Evidence map›Paper›PMID 40925861›Full record

ArticleJMIR medical informatics2025

Real-World Evaluation of AI-Driven Diabetic Retinopathy Screening in Public Health Settings: Validation and Implementation Study.

Mona Duggal, Anshul Chauhan, Vishali Gupta, Ankita Kankaria, Deepmala Budhija, Priyanka Verma, Vaibhav Miglani, Preeti Syal, Gagandeep Kaur, Lakshay Kumar and 6 more

Abstract readValidation Study
In one paragraph

Article in JMIR medical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mona Duggal *ICMR-National Institute for Research in Digital Health and Data Science (NIRDHDS), Ansari Nagar East, New Delhi, 110029, India, 91-11-26588803.ORCID 0000-0002-9404-2871
Anshul Chauhan *Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0000-0002-2434-935X
Vishali GuptaAdvanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0000-0001-8216-4620
Ankita KankariaDepartment of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0000-0002-4641-7333
Deepmala BudhijaAdvanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0009-0007-8095-3766
Priyanka VermaAdvanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0000-0003-0085-0104
Vaibhav MiglaniAdvanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0000-0002-0189-8890
Preeti SyalNational Institute of Transforming India (NITI) Aayog, Delhi, India.ORCID 0009-0003-8461-8528
Gagandeep KaurAdvanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0009-0003-0403-8997
Lakshay KumarAdvanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0009-0007-4026-9935
Naveen MutyalaAdvanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.ORCID 0009-0007-2289-4438
Rishabh BezbaruahNational Institute of Transforming India (NITI) Aayog, Delhi, India.ORCID 0009-0005-8940-8364
Nayanshi SoodDepartment of Ophthalmology, Department of Health and Family Welfare, Mohali, Punjab, India.ORCID 0000-0003-1329-8267
Ashleigh KernohanGlobal Health Economics Centre, Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-5514-3186
Geeta MenonFrimley Health NHS Foundation Trust, Frimley, United Kingdom.ORCID 0009-0003-5996-0137
Luke ValeGlobal Health Economics Centre, Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0001-8574-8429

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Artificial intelligence (AI) algorithms offer an effective solution to alleviate the burden of diabetic retinopathy (DR) screening in public health settings. However, there are challenges in translating diagnostic performance and its application when deployed in real-world conditions. Objective: This study aimed to assess the technical feasibility of integration and diagnostic performance of validated DR screening (DRS) AI algorithms in real-world outpatient public health settings. Methods: Prior to integrating an AI algorithm for DR screening, the study involved several steps: (1) Five AI companies, including four from India and one international company, were invited to evaluate their diagnostic performance using low-cost nonmydriatic fundus cameras in public health settings; (2) The AI algorithms were prospectively validated on fundus images from 250 people with diabetes mellitus, captured by a trained optometrist in public health settings in Chandigarh Tricity in North India. The performance evaluation used diagnostic metrics, including sensitivity, specificity, and accuracy, compared to human grader assessments; (3) The AI algorithm with better diagnostic performance was integrated into a low-cost screening camera deployed at a community health center (CHC) in the Moga district of Punjab, India. For AI algorithm analysis, a trained health system optometrist captured nonmydriatic images of 343 patients. Results: Three web-based AI screening companies agreed to participate, while one declined and one chose to withdraw due to low specificity identified during the interim analysis. The three AI algorithms demonstrated variable diagnostic performance, with sensitivity (60%-80%) and specificity (14%-96%). Upon integration, the better-performing algorithm AI-3 (sensitivity: 68%, specificity: 96, and accuracy: 88·43%) demonstrated high sensitivity of image gradability (99.5%), DR detection (99.6%), and referral DR (79%) at the CHC. Conclusions: This study highlights the importance of systematic AI validation for responsible clinical integration, demonstrating the potential of DRS to improve health care access in resource-limited public health settings.

Indexed as

Artificial IntelligenceDiabetic RetinopathyMass ScreeningPublic HealthAdultAlgorithmsFemaleHumansIndiaMaleMiddle AgedSensitivity and Specificityartificial intelligencediabetic retinopathyscreeningScreening, public health settingsvalidation, implementation, integration

Identifiers

PMID40925861
PMCPMC12419978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.